CARDIOCOMM SOLUTIONS, INC. Financials CardioComm Solutions, Inc.
Equities
EKG
CA14159N2086
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.01 CAD | 0.00% |
|
0.00% | 0.00% |
| Feb. 16 | CardioComm Solutions, Inc. Appoint Robin Black to Board of Directors | CI |
| Jan. 09 | Cardiocomm Solutions, Inc. Announces CFO Changes | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 6.854 | 5.498 | 4.921 | 7.782 | 4.51 | 3.773 |
| Enterprise Value (EV) 1 | 7.106 | 5.958 | 5.376 | 7.966 | 4.84 | 4.061 |
| P/E ratio | 171 x | -9.51 x | -4.6 x | -122 x | 30,000 x | -1,563 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 3.94 x | 5.11 x | 5.63 x | 9.32 x | 6.61 x | 3.79 x |
| EV / Revenue | 4.08 x | 5.54 x | 6.15 x | 9.54 x | 7.09 x | 4.08 x |
| EV / EBITDA | 29 x | -13.4 x | -6.68 x | -559 x | -29.6 x | -233 x |
| EV / FCF | -32 x | 117 x | 13.5 x | 2,372 x | -11.2 x | 265 x |
| FCF Yield | -3.12% | 0.86% | 7.43% | 0.04% | -8.96% | 0.38% |
| Price to Book | 14 x | -80.5 x | -5.48 x | -11.6 x | -10.7 x | -9.26 x |
| Nbr of stocks (in thousands) | 137,089 | 137,440 | 140,614 | 141,490 | 150,343 | 150,915 |
| Reference price 2 | 0.0500 | 0.0400 | 0.0350 | 0.0550 | 0.0300 | 0.0250 |
| Announcement Date | 4/30/18 | 4/30/19 | 6/15/20 | 4/30/21 | 5/2/22 | 8/3/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.74 | 1.076 | 0.8749 | 0.8348 | 0.6825 | 0.9958 |
| EBITDA 1 | 0.2451 | -0.4442 | -0.8046 | -0.0143 | -0.1636 | -0.0174 |
| EBIT 1 | 0.2441 | -0.4454 | -0.8072 | -0.0182 | -0.1681 | -0.0225 |
| Operating Margin | 14.03% | -41.41% | -92.27% | -2.18% | -24.63% | -2.26% |
| Earnings before Tax (EBT) 1 | 0.0396 | -0.5771 | -1.062 | -0.0636 | 0.000283 | -0.002455 |
| Net income 1 | 0.0396 | -0.5771 | -1.062 | -0.0636 | 0.000283 | -0.002455 |
| Net margin | 2.28% | -53.65% | -121.4% | -7.62% | 0.04% | -0.25% |
| EPS 2 | 0.000293 | -0.004205 | -0.007612 | -0.000449 | 0.000001 | -0.000016 |
| Free Cash Flow 1 | -0.222 | 0.0511 | 0.3996 | 0.003359 | -0.4334 | 0.0153 |
| FCF margin | -12.75% | 4.75% | 45.67% | 0.4% | -63.51% | 1.54% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/30/18 | 4/30/19 | 6/15/20 | 4/30/21 | 5/2/22 | 8/3/23 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.25 | 0.46 | 0.45 | 0.18 | 0.33 | 0.29 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.026 x | -1.036 x | -0.5655 x | -12.93 x | -2.015 x | -16.56 x |
| Free Cash Flow 1 | -0.22 | 0.05 | 0.4 | 0 | -0.43 | 0.02 |
| ROE (net income / shareholders' equity) | 16.4% | -274% | 220% | 8.12% | -0.05% | 0.59% |
| ROA (Net income/ Total Assets) | 11.3% | -21.2% | -71.4% | -3.33% | -24.8% | -3.67% |
| Assets 1 | 0.3491 | 2.725 | 1.488 | 1.91 | -0.001141 | 0.0669 |
| Book Value Per Share 2 | 0 | -0 | -0.0100 | -0 | -0 | -0 |
| Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capex 1 | 0 | 0 | 0.01 | 0.01 | - | 0 |
| Capex / Sales | 0.07% | 0.23% | 0.67% | 1.6% | - | 0.22% |
| Announcement Date | 4/30/18 | 4/30/19 | 6/15/20 | 4/30/21 | 5/2/22 | 8/3/23 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 1.1M | |
| +4.36% | 32.47B | |
| +16.51% | 7.45B | |
| +21.38% | 3.89B | |
| -16.29% | 3.17B | |
| -25.96% | 1.28B | |
| -36.14% | 1.09B | |
| -35.42% | 902M | |
| -0.13% | 893M | |
| -24.12% | 857M |
- Stock Market
- Equities
- EKG Stock
- Financials CardioComm Solutions, Inc.
